نتایج جستجو برای: serous prognosis

تعداد نتایج: 125543  

Journal: :Pathology discovery 2013
Vijaya Galic Carrie J Shawber Claire Reeves Monjri Shah Aino Murtomaki Jason Wright Thomas Herzog Guo Xia Tong Jan Kitajewski

BACKGROUND Notch family members function as both oncogenes and tumor suppressors. NOTCH2 is down-regulated in colon cancer, and reduced expression is associated with a less differentiated, more aggressive phenotype, and reduced overall survival. NOTCH2 has also been shown to have pro-apoptotic and growth suppressive effects in thyroid carcinoma, and carcinoid tumors. The expression pattern of N...

2018
Jue Zhang Meng Xu Han Gao Jin-Chen Guo Yu-Lin Guo Miao Zou Xu-Feng Wu

Ovarian cancer is the seventh most common type of cancer and the eighth most common cause of cancer-associated mortality among women. A number of studies have hypothesized that the expression status of certain genes may be used to predict prognosis in ovarian cancer. In the present study, the RNA expression data from next-generation sequencing and the clinical information of 413 patients from T...

2011
Michael P. Stany Vinod Vathipadiekal Laurent Ozbun Rebecca L. Stone Samuel C. Mok Hui Xue Takashi Kagami Yuwei Wang Jessica N. McAlpine David Bowtell Peter W. Gout Dianne M. Miller C. Blake Gilks David G. Huntsman Susan L. Ellard Yu-Zhuo Wang Pablo Vivas-Mejia Gabriel Lopez-Berestein Anil K. Sood Michael J. Birrer

Clear cell ovarian cancer is an epithelial ovarian cancer histotype that is less responsive to chemotherapy and carries poorer prognosis than serous and endometrioid histotypes. Despite this, patients with these tumors are treated in a similar fashion as all other ovarian cancers. Previous genomic analysis has suggested that clear cell cancers represent a unique tumor subtype. Here we generated...

2015
Kim Moran-Jones Brian S. Gloss Rajmohan Murali David K. Chang Emily K. Colvin Marc D. Jones Samuel Yuen Viive M. Howell Laura M. Brown Carol W. Wong Suzanne M. Spong Christopher J. Scarlett Neville F. Hacker Sue Ghosh Samuel C. Mok Michael J. Birrer Goli Samimi

Ovarian cancer is the most common cause of death among women with gynecologic cancer. We examined molecular profiles of fibroblasts from normal ovary and high-grade serous ovarian tumors to identify novel therapeutic targets involved in tumor progression. We identified 2,300 genes that are significantly differentially expressed in tumor-associated fibroblasts. Fibroblast expression of one of th...

Journal: :Cancer letters 2015
Ream Langhe Lucy Norris Feras Abu Saadeh Gordon Blackshields Rachel Varley Ashling Harrison Noreen Gleeson Cathy Spillane Cara Martin Dearbhaile M O'Donnell Tom D'Arcy John O'Leary Sharon O'Toole

Ovarian cancer is the seventh most common cancer in women and the most frequent cause of gynaecological malignancy-related mortality in women. Currently, no standardized reliable screening test exists. MicroRNA profiling has allowed the identification of signatures associated with diagnosis, prognosis and response to treatment of human tumours. The aim of this study was to determine if a microR...

Journal: :International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2014
Satoru Sagae Nobuyuki Susumu Akila N Viswanathan Daisuke Aoki Floor J Backes Diane M Provencher Michelle Vaughan Carien L Creutzberg Christian Kurzeder Gunnar Kristensen Chulmin Lee Jean-Emmanuel Kurtz Rosalind M Glasspool William Small

OBJECTIVES Uterine serous carcinoma (USC) represents a rare and aggressive histologic subtype of endometrial cancer, associated with a poor prognosis. This article critically reviews the literature pertinent to the epidemiology, pathology, molecular biology, diagnosis, management, and perspectives of patients with USC. METHODS As one of a series of The Gynecologic Cancer InterGroup (GCIG) Rar...

2012
David A. Engler Sumeet Gupta Whitfield B. Growdon Ronny I. Drapkin Mai Nitta Petra A. Sergent Serena F. Allred Jenny Gross Michael T. Deavers Wen-Lin Kuo Beth Y. Karlan Bo R. Rueda Sandra Orsulic David M. Gershenson Michael J. Birrer Joe W. Gray Gayatry Mohapatra

Ovarian cancer is the fifth leading cause of cancer death in women. Ovarian cancers display a high degree of complex genetic alterations involving many oncogenes and tumor suppressor genes. Analysis of the association between genetic alterations and clinical endpoints such as survival will lead to improved patient management via genetic stratification of patients into clinically relevant subgro...

Background & Objective: The common epithelial ovarian tumors are classified into serous, mucinous, clear cell, endometrioid, the Brenner, mixed, and undifferentiated types. Cytoskeleton intermediate filament composition of ovarian tissues indicates that the cytokeratin and vimentin are observed in ovarian surface epithelium along with the common ovaria...

2012
K Bramis A Petrou A Papalambros A Manzelli E Mantonakis N Brennan E Felekouras

BACKGROUND Serous adenomas represent 1-2% of pancreatic neoplasms and typically are asymptomatic not requiring any treatment and simple observation is the option of choice. Although, they carry a realistic risk of malignancy despite the general view that they never become malignant. We report a case, which, according to our best knowledge is the 27th case reported in the literature. METHODS W...

Journal: :International journal of clinical and experimental pathology 2010
Ning Chen Xiaofang Yi Nisreen Abushahin Shujie Pang Donna Zhang Beihua Kong Wenxin Zheng

Endometrial serous carcinoma (ESC) is the most aggressive subtype of endometrial cancer. Its aggressive behavior and poor clinical outcome may be partially attributed to lack of early diagnostic markers and unclear patho-genesis. The transcription factor Erythroid-E2-related factor 2 (Nrf2) is a recently identified protein marker, which plays a role in carcinogenesis as well as responsible for ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید